Clinical Trial Update: Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas [Phase 4]

View source ↗

Summary

Phase 4 trial comparing daptomycin to vancomycin in cellulitis shows completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellulitis

Drugs mentioned

• Cubicin (daptomycin)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Cellulitis | Phase 4 | Status: COMPLETED